Tuesday, 5 February 2019

Merck CEO Frazier plans to testify at Senate drug pricing hearing

U.S. drug company Merck & Co Inc said on Tuesday that its Chief Executive Ken Frazier plans to testify at a Senate hearing later this month examining rising prescription drug prices.


No comments:

Post a Comment